|

68Ga-FAPI Clinical Trials

3 actively recruiting trials

No change since May 2026

Also known as: 68Ga-FAPI injection, 68Ga-Fibroblast activation protein Inhibitor, 68Ga-fibroblast activation protein inhibitor

Pipeline

Early 1: 1Phase 1/2: 1

Top Sponsors

  • Peking Union Medical College Hospital2
  • Zhongnan Hospital1

Indications

  • Cancer2
  • Sjogren's Syndrome1
  • Fibroblast Activation Protein Inhibitor1
  • Arthritis1
  • Malignant Neoplasm1

Other3 trials

68Ga-FAPI PET/CT in Malignant Tumors
N/A
68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
Early 1
Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.